Joint pain and disorders are primarily caused by osteoarthritis, which affects over 20 million people in the United States annually. With a predicted increase in life expectancy and an increasingly active population, the number of patients who will seek treatment for significant pain and disability secondary to joint pain will undoubtedly continue to escalate. Initial therapies for joint pain and disorders include anti-inflammatory medications, activity modification, and/or physical rehabilitation. Failure of these nonsurgical methods to provide adequate pain relief may prompt treatment with viscosupplementation injection therapy. Surgical interventions for joint pain and disorders, such as total knee replacement or total hip replacement, are becoming increasingly viable options in younger subsets of patients.